Skip to main content Skip to search Skip to main navigation

EU MDR: Decision on delay by one year

On 17 April 2020, the European Parliament voted by 693 to one votes and with two abstentions to delay the entry into force of the EU Medical Device Regulation (MDR) by one year - to 26 May 2021. 

Initially, the MDR was to apply from 26 May 2020. However, due to the Covid 19 crisis, medical device manufacturers experience heavy workloads in providing the necessary medical devices. To avoid shortages, six Members of the European Parliament submitted a proposal calling for a delay of the MDR (we reported).
The new date of entry into force is expected to be published in the Official Journal of the European Union on 26 May 2020.
The EU In-Vitro Diagnostic Medical Device Regulation (IVDR) is not affected. As scheduled, it is currently to be applicable as of May 26, 2022. However, MedTech Europe is already calling for this date to be delayed, as, among other things, only a few Notified Bodies have been designated.


Source:

European Parliament: Press release: Parliament decides to postpone new requirements for medical devices

MedTech Europe: MedTech Europe welcomes the amendment of the Medical Devices Regulation and urges similar action for the IVD Regulation

Meet the GMP Compliance Adviser

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be Interested in the Following Articles:

PIC/S: Jordan FDA Joins PIC/S

PIC/S: Jordan FDA Joins PIC/S

On 1 January 2026, the Jordan Food & Drug Administration (JFDA) became the 57th PIC/S Participating Authority.

Read more
Swissmedic: Scientific GMDP Meetings

Swissmedic: Scientific GMDP Meetings

Swissmedic offers companies holding or seeking a Swissmedic manufacturing or distribution license the opportunity to discuss project-specific GMP and GDP topics in Scientific GMDP Meetings.

Read more
Purified Water – The new Chinese Pharmacopoeias and What Happens Next? NEU

Purified Water – The new Chinese Pharmacopoeias and What Happens Next? NEU

A new Chinese Pharmacopoeia was published in 2025. This has some significant implications for the pharmaceutical water industry, which we will discuss in more detail in this article. Firstly, it is important to note that cold WFI systems are now permitted worldwide and can be used across the board.
Read more
What are the requirements for gas distribution systems?

What are the requirements for gas distribution systems?

You can view the answer here:
Read more
What are the quality requirements for pharmaceutical gases?

What are the quality requirements for pharmaceutical gases?

You can view the answer here:
Read more
EMA: Update on the Guideline “Stability Testing for Variations”

EMA: Update on the Guideline “Stability Testing for Variations”

The EMA has updated the guideline on stability testing for variations (Revision 3, applicable from 15 January 2026).
Read more
Previous
Next